¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå Á¶»ç ¹× ¿¹Ãø : Á¦Ç° À¯Çü, ±â¼ú À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº° ºÐ¼®(2023-2030³â)
Global Glycated Hemoglobin Testing Equipment Market Size study & Forecast, by Product Type, by Technology Type, by End-User and Regional Analysis, 2023-2030
»óǰÄÚµå
:
1303541
¸®¼Ä¡»ç
:
Bizwit Research & Consulting LLP
¹ßÇàÀÏ
:
2023³â 07¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
´çÈÇ÷»ö¼Ò´Â Á¾Á¾ Çì¸ð±Û·Îºó A1c(HbA1c)¶ó°í ºÒ¸®¸ç, Àå±â°£ÀÇ Æò±Õ Ç÷´çÄ¡¸¦ ÃøÁ¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â Çì¸ð±Û·ÎºóÀÇ ÇÑ ÇüÅÂÀÔ´Ï´Ù.
Çì¸ð±Û·ÎºóÀº ÀûÇ÷±¸¿¡ µé¾îÀÖ´Â ´Ü¹éÁú·Î Àü½Å¿¡ »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â ¿ªÇÒÀ» ÇÕ´Ï´Ù. Ç÷¾× ³» Æ÷µµ´ç ºÐÀÚ°¡ Çì¸ð±Û·Îºó°ú °áÇÕÇÏ¸é ´çȶó´Â °úÁ¤À» °ÅÃÄ ´çÈÇ÷»ö¼ÒÀÌ Çü¼ºµË´Ï´Ù. ´çÈÇ÷»ö¼Ò ¼öÄ¡´Â ÀûÇ÷±¸ ¼ö¸í(º¸Åë ¾à 2-3°³¿ù)ÀÇ Æò±Õ Ç÷Áß Æ÷µµ´ç ³óµµ¸¦ ¹Ý¿µÇÕ´Ï´Ù. ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀåÀº ´ç´¢º´ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
±¹Á¦´ç´¢º´¿¬¸Í(International Diabetes Federation)ÀÇ 2019³â ÀÚ·á¿¡ µû¸£¸é, ´ç´¢º´À» ¾Î°í ÀÖ´Â ¼ºÀÎÀÇ ¼ö´Â ¾à 463¸¸ ¸íÀ̸ç, 2045³â¿¡´Â ¼¼°èÀûÀ¸·Î 7¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î Ãß»êµË´Ï´Ù. ¼¼°èÀºÇà ±×·ìÀº 2020³â 7¾ï 2,700¸¸ ¸íÀ̾ú´ø ¼¼°è ³ëÀÎ Àα¸°¡ ÇâÈÄ 30³â°£ 3¹è Áõ°¡ÇØ 2050³â¿¡´Â 15¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌó·³ ÀÌ Áö¿ªÀÇ ´ç´¢º´ À¯º´·ü Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ç´¢º´ °ü·Ã ¿¬±¸ °³¹ß Áõ°¡, ÁÂ½Ä »ýȰ ½À°ü, ¿¾ÇÇÑ °Ç° °ü¸® »óŸ¦ ÃÊ·¡ÇÏ´Â ½Ä½À°ü Àå¾Ö, ´ç´¢º´ Áø´Ü ±â¼úÀÇ ¹ßÀüÀº ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ´çÈÇ÷»ö¼Ò °Ë»ç ÀåºñÀÇ ³ôÀº ºñ¿ë°ú ´ç´¢º´ °ü¸® ÀÎ½Ä ºÎÁ·Àº 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ Àü¸ÁÀÔ´Ï´Ù.
¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ºê·£µå Á¦Ç°ÀÇ Àαâ¿Í ÀÌ Áö¿ªÀÇ Áúº´·ü Áõ°¡, ÀÌ Áö¿ªÀÇ R&D Ȱµ¿ Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡¿Í ¸¸¼º Áúȯ Áõ°¡, Á¦Ç° °³¹ßÀ» À§ÇÑ Á¦ÈÞ ¹× ÆÄÆ®³Ê½Ê Áõ°¡, ÁÖ¿ä Âü°¡ÀÚÀÇ Áö¸®Àû È®Àå, ½ÃÀå ÁøÀÔÀÚÀÇ Àû±ØÀûÀÎ ½ÃÀå ÁøÀÔ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° À¯Çü¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇöȲ
- ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2020-2030³â
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : Áö¿ªº°, 2020-2030³â
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : Á¦Ç° À¯Çüº°, 2020-2030³â
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : ±â¼ú À¯Çüº°, 2020-2030³â
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2030³â
- ÁÖ¿ä µ¿Çâ
- Á¶»ç ¹æ¹ý
- Á¶»ç ÀüÁ¦Á¶°Ç
Á¦2Àå ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå, Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ¸ñÀû
- ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ´ë»ó³âµµ
- ÅëÈ È¯»êÀ²
Á¦3Àå ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå ¿ªÇÐ
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
- ½ÃÀå ±âȸ
Á¦4Àå ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : »ê¾÷ ºÐ¼®
- Porter's Five Forces ¸ðµ¨
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ¹ÙÀ̾îÀÇ ±³¼··Â
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï ±â¾÷°£ °æÀï °ü°è
- Porter's Five ForcesÀÇ ¿µÇ⠺м®
- PEST ºÐ¼®
- Á¤Ä¡
- °æÁ¦
- »çȸ
- 񃬣
- ȯ°æ
- ¹ý·ü
- ÁÖ¿ä ÅõÀÚ ±âȸ
- ÁÖ¿ä ¼º°ø Àü·«
- COVID-19ÀÇ ¿µÇ⠺м®
- ÆÄ±«Àû µ¿Çâ
- ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
- ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È
Á¦5Àå ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : Á¦Ç° À¯Çüº°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : Á¦Ç° À¯Çüº°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : Á¦Ç° À¯Çüº° ÃßÁ¤¡¤¿¹Ãø2020-2030³â
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
- ´Ù±â´É °Ë»ç±â±â
- °£ÀÌÇü °Ë»ç±â±â
Á¦6Àå ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : ±â¼ú À¯Çüº°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : ±â¼ú À¯Çüº°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : ±â¼ú À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
- À̿ ±³È¯ °í¼º´É ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ(HPLC)
- ¸é¿ªÃøÁ¤¹ý
- ºÀ»ê¿° ģȼº Å©·Î¸¶Åä±×·¡ÇÇ
- Á÷Á¢ È¿¼Ò ÃøÁ¤¹ý
Á¦7Àå ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤¡¤¿¹Ãø2020-2030³â
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
- º´¿ø
- °Ç° Áø´Ü ±â°ü
- ¿¬±¸±â°ü
- ±âŸ
Á¦8Àå ¼¼°èÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå : Áö¿ªº° ºÐ¼®
- ÁÖ¿ä ±¹°¡
- ÁÖ¿ä ½ÅÈï ±¹°¡
- ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
- ºÏ¹Ì
- ¹Ì±¹
- Á¦Ç° À¯Çü ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ±â¼ú À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ij³ª´Ù
- À¯·´ÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå ÇöȲ
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå ÇöȲ
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ´çÈÇ÷»ö¼Ò °Ë»ç Àåºñ ½ÃÀå ÇöȲ
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï Á¤º¸
- ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
- ÁÖ¿ä ½ÃÀå Àü·«
- ±â¾÷ °³¿ä
- Abbott Laboratories
- ÁÖ¿ä Á¤º¸
- °³¿ä
- À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
- Á¦Ç° °³¿ä
- ÃÖ±Ù µ¿Çâ
- F. Hoffmann-La Roche Ltd.
- Alere Inc.
- Bio-Rad Laboratories, Inc.
- Beckman Coulter, Inc.
- Bayer AG
- Randox Laboratories Ltd.
- Tosoh Corporation
- ARKRAY, Inc.
- A. Menarini Diagnostics Ltd.
Á¦10Àå Á¶»ç °úÁ¤
- Á¶»ç °úÁ¤
- µ¥ÀÌÅÍ ¸¶ÀÌ´×
- ºÐ¼®
- ½ÃÀå ÃßÁ¤
- °ËÁõ
- ÃâÆÇ
- Á¶»ç ¼Ó¼º
- Á¶»ç ÀüÁ¦Á¶°Ç
LSH
¿µ¹® ¸ñÂ÷
Global Glycated Hemoglobin Testing Equipment Market is valued at approximately USD xx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2023-2030. Glycated hemoglobin, often referred to as hemoglobin A1c (HbA1c), is a form of hemoglobin that is used to measure average blood glucose levels over a prolonged period. Hemoglobin is a protein found in red blood cells responsible for carrying oxygen throughout the body. When glucose molecules in the bloodstream bind to hemoglobin, a process called glycation occurs, resulting in the formation of glycated hemoglobin. The level of glycated hemoglobin reflects the average blood glucose concentration over the lifespan of red blood cells, which is typically around two to three months. The Glycated Hemoglobin Testing Equipment market is expanding because of factors such as rising prevalence of diabetes and rising geriatric population.
According to the International Diabetes Federation's edition from 2019, there were around 463 adults living with diabetes, and by 2045, there would be 700 million adults worldwide. The World Bank Group projects that the world's elderly population, which was 727 million in 2020, will triple over the next three decades and reach 1.5 billion in 2050. Thus, rising prevalence of diabetes and rising geriatric population in the region is fostering market growth. In addition, increased R&D on diabetes, sedentary lifestyles, poor diet that results in subpar healthcare conditions, and improvements in technology for diagnosing diabetes are creating a lucrative opportunity for market growth. However, the high cost of Glycated Hemoglobin Testing Equipment and lack of diabetic care awareness stifle market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Glycated Hemoglobin Testing Equipment Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 as a result of the popularity of branded goods and the region's rising disease rates in the region, and rising research and development activities in the region. Asia Pacific is anticipated to witness significant growth during the forecast period as a result of factors including growing geriatric population and rising prevelance of chronic disease, an increase in the number of collaborations and partnership for product development, geographic expansion of key players, and active participation of governments in the market space.
Major market players included in this report are:
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Alere Inc.
- Bio-Rad Laboratories, Inc.
- Beckman Coulter, Inc.
- Bayer AG
- Randox Laboratories Ltd.
- Tosoh Corporation
- ARKRAY, Inc.
- A.Menarini Diagnostics Ltd.
Recent Developments in the Market:
- In June 2021, the U.S. Food and Drug Administration approved Abbott Laboratories' Afinion HbA1c Dx assay for use as a point-of-care test. They declared that the Afinion 2 analyzer would endorse this product.
Global Glycated Hemoglobin Testing Equipment Market Report Scope:
- Historical Data: 2020 - 2021
- Base Year for Estimation: 2022
- Forecast period: 2023-2030
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Product Type, Technology Type, End-User, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.
By Product Type:
- Multifunctional Testing Equipment
- Simple Testing Equipment
By Technology Type:
- Ion-Exchange High Performance Liquid Chromatography (HPLC)
- Immunoassay
- Boronate Affinity Chromatography
- Direct Enzymatic Assay
By End-User:
- Hospitals
- Physical Examination Institutions
- Research Institutions
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Glycated Hemoglobin Testing Equipment Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Glycated Hemoglobin Testing Equipment Market, by Product Type, 2020-2030 (USD Billion)
- 1.2.3. Glycated Hemoglobin Testing Equipment Market, by Technology Type, 2020-2030 (USD Billion)
- 1.2.4. Glycated Hemoglobin Testing Equipment Market, by End-User, 2020-2030 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Glycated Hemoglobin Testing Equipment Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Glycated Hemoglobin Testing Equipment Market Dynamics
- 3.1. Glycated Hemoglobin Testing Equipment Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing incidence of diabetes
- 3.1.1.2. Growing Geriatric Population
- 3.1.2. Market Challenges
- 3.1.2.1. High Cost of Glycated Hemoglobin Testing Equipment
- 3.1.2.2. Lack of awareness
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising investment in research and development activities
- 3.1.3.2. Rising technological advancement
Chapter 4. Global Glycated Hemoglobin Testing Equipment Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Glycated Hemoglobin Testing Equipment Market, by Product Type
- 5.1. Market Snapshot
- 5.2. Global Glycated Hemoglobin Testing Equipment Market by Product Type, Performance - Potential Analysis
- 5.3. Global Glycated Hemoglobin Testing Equipment Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
- 5.4. Glycated Hemoglobin Testing Equipment Market, Sub Segment Analysis
- 5.4.1. Multifunctional Testing Equipment
- 5.4.2. Simple Testing Equipment
Chapter 6. Global Glycated Hemoglobin Testing Equipment Market, by Technology Type
- 6.1. Market Snapshot
- 6.2. Global Glycated Hemoglobin Testing Equipment Market by Technology Type, Performance - Potential Analysis
- 6.3. Global Glycated Hemoglobin Testing Equipment Market Estimates & Forecasts by Technology Type 2020-2030 (USD Billion)
- 6.4. Glycated Hemoglobin Testing Equipment Market, Sub Segment Analysis
- 6.4.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
- 6.4.2. Immunoassay
- 6.4.3. Boronate Affinity Chromatography
- 6.4.4. Direct Enzymatic Assay
Chapter 7. Global Glycated Hemoglobin Testing Equipment Market, by End-User
- 7.1. Market Snapshot
- 7.2. Global Glycated Hemoglobin Testing Equipment Market by End-User, Performance - Potential Analysis
- 7.3. Global Glycated Hemoglobin Testing Equipment Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
- 7.4. Glycated Hemoglobin Testing Equipment Market, Sub Segment Analysis
- 7.4.1. Hospitals
- 7.4.2. Physical Examination Institutions
- 7.4.3. Research Institutions
- 7.4.4. Others
Chapter 8. Global Glycated Hemoglobin Testing Equipment Market, Regional Analysis
- 8.1. Top Leading Countries
- 8.2. Top Emerging Countries
- 8.3. Glycated Hemoglobin Testing Equipment Market, Regional Market Snapshot
- 8.4. North America Glycated Hemoglobin Testing Equipment Market
- 8.4.1. U.S. Glycated Hemoglobin Testing Equipment Market
- 8.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
- 8.4.1.2. Technology Type breakdown estimates & forecasts, 2020-2030
- 8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Glycated Hemoglobin Testing Equipment Market
- 8.5. Europe Glycated Hemoglobin Testing Equipment Market Snapshot
- 8.5.1. U.K. Glycated Hemoglobin Testing Equipment Market
- 8.5.2. Germany Glycated Hemoglobin Testing Equipment Market
- 8.5.3. France Glycated Hemoglobin Testing Equipment Market
- 8.5.4. Spain Glycated Hemoglobin Testing Equipment Market
- 8.5.5. Italy Glycated Hemoglobin Testing Equipment Market
- 8.5.6. Rest of Europe Glycated Hemoglobin Testing Equipment Market
- 8.6. Asia-Pacific Glycated Hemoglobin Testing Equipment Market Snapshot
- 8.6.1. China Glycated Hemoglobin Testing Equipment Market
- 8.6.2. India Glycated Hemoglobin Testing Equipment Market
- 8.6.3. Japan Glycated Hemoglobin Testing Equipment Market
- 8.6.4. Australia Glycated Hemoglobin Testing Equipment Market
- 8.6.5. South Korea Glycated Hemoglobin Testing Equipment Market
- 8.6.6. Rest of Asia Pacific Glycated Hemoglobin Testing Equipment Market
- 8.7. Latin America Glycated Hemoglobin Testing Equipment Market Snapshot
- 8.7.1. Brazil Glycated Hemoglobin Testing Equipment Market
- 8.7.2. Mexico Glycated Hemoglobin Testing Equipment Market
- 8.8. Middle East & Africa Glycated Hemoglobin Testing Equipment Market
- 8.8.1. Saudi Arabia Glycated Hemoglobin Testing Equipment Market
- 8.8.2. South Africa Glycated Hemoglobin Testing Equipment Market
- 8.8.3. Rest of Middle East & Africa Glycated Hemoglobin Testing Equipment Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Abbott Laboratories
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Recent Developments
- 9.3.2. F. Hoffmann-La Roche Ltd.
- 9.3.3. Alere Inc.
- 9.3.4. Bio-Rad Laboratories, Inc.
- 9.3.5. Beckman Coulter, Inc.
- 9.3.6. Bayer AG
- 9.3.7. Randox Laboratories Ltd.
- 9.3.8. Tosoh Corporation
- 9.3.9. ARKRAY, Inc.
- 9.3.10. A. Menarini Diagnostics Ltd.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption
°ü·ÃÀÚ·á